158
Participants
Start Date
March 31, 2007
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Estriol
Estriol 8 mg capsule, once per day, duration of treatment is 2 years
Placebo
Placebo capsule, once a day, treatment duration is 2 years
Copaxone
Injection, once a day, all subjects
University of Pennsylvania, Philadelphia
Ohio State University, Columbus
University of Minnesota, Minneapolis
University of Chicago, Chicago
Washington University, St Louis
University of Kansas, Kansas City
University of Colorado, Aurora
Western Institute for Biomedical Research, Salt Lake City
Mayo Clinic, Scottsdale
University of New Mexico, Albuquerque
University of California, Los Angeles, Los Angeles
Johns Hopkins University, Baltimore
Dartmouth Medical School, Lebanon
UMDNJ-Robert Wood Johnson Medical Center, New Brunswick
University of Texas Southwestern, Dallas
Montreal Neurological Institute, Montreal
Collaborators (1)
Washington University School of Medicine
OTHER
University of Texas Southwestern Medical Center
OTHER
Ohio State University
OTHER
University of Medicine and Dentistry of New Jersey
OTHER
University of Chicago
OTHER
University of Utah
OTHER
Johns Hopkins University
OTHER
University of Kansas Medical Center
OTHER
University of Minnesota
OTHER
Mayo Clinic
OTHER
University of Colorado, Denver
OTHER
University of New Mexico
OTHER
University of Pennsylvania
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
National Multiple Sclerosis Society
OTHER
National Institutes of Health (NIH)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of California, Los Angeles
OTHER